000 | 01751ngm a2200373 a 4500 | ||
---|---|---|---|
001 | HST67.1912_1_2_252 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 080121s2008 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a1912 _bHenry Stewart Talks |
035 | _a(UkLoHST)1075 | ||
035 | _a(UkLU-K)001104074 | ||
040 |
_aUkLU-K _beng _cUkLU-K |
||
100 | 1 |
_aKolassa, E. M. _4spk |
|
245 | 1 | 0 |
_aPricing in the pharmaceutical industry _h[electronic resource] / _cE.M. (Mick) Kolassa. |
260 |
_aLondon : _bHenry Stewart Talks, _c2009. |
||
300 |
_a1 online resource (1 streaming video file (41 min.) : _bcolor, sound). |
||
490 | 1 |
_aPharmaceutical marketing : latest insights, challenges, solutions and trends, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Understanding how prices are currently set in the global pharmaceutical industry -- The importance of developing a pricing strategy, as opposed to simply setting a price -- The factors that must be considered when taking pricing actions -- The implications of poor pricing decisions. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 |
_aDrugs _xMarketing. |
|
650 | 0 |
_aPharmaceutical industry _xMarketing. |
|
650 | 2 | _aCosts and Cost Analysis. | |
650 | 2 | _aDrug Industry. | |
650 | 2 | _aPharmaceutical Preparations. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pPharmaceutical marketing : latest insights, challenges, solutions and trends. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/1075/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/271/ _3Series |
999 |
_c78511 _d78511 |